MarketCap
Retractable Technologies RVP
$ 0.58
0.17%
Facebook
X
Telegram
Retractable Technologies Interest Expense | RVP
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Retractable Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 152 K | 171 K | 227 K | 260 K | 167 K | 177 K | 211 K | 213 K | 220 K | 223 K | 231 K | 231 K | 240 K | 303 K | 21.9 K | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 303 K | 21.9 K | 203 K |
Quarterly Interest Expense Retractable Technologies
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 33.5 K | - | 36.1 K | 37.5 K | 43.6 K | - | 40.3 K | 38.4 K | 47.1 K | - | 52.9 K | 54.7 K | 65.1 K | - | 36.1 K | 36 K | 33.8 K | 36 K | 40.7 K | 43.5 K | 45.9 K | 41 K | 42 K | 44 K | 50 K | - | 53 K | 58 K | 48.1 K | - | 52 K | 56.7 K | 49.6 K | - | 58.3 K | 53.1 K | 53.8 K | - | 55.2 K | 56 K | 57.2 K | - | 59.5 K | 60.6 K | 52.1 K | - | 69 K | 70.3 K | 72.1 K | - | 62.5 K | 65.5 K | 56.9 K |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 72.1 K | 33.5 K | 50.4 K |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Repro Med Systems
KRMD
|
9.91 K | $ 3.13 | -1.26 % | $ 145 M |  USA |
 |
Milestone Scientific
MLSS
|
60.3 K | $ 0.31 | 1.02 % | $ 25.4 M | USA |
 |
Merit Medical Systems
MMSI
|
-2.39 M | $ 94.16 | 0.92 % | $ 5.57 B | USA |
 |
Alcon
ALC
|
204 M | $ 70.0 | -0.24 % | $ 34.5 B |  Schweiz |
 |
AtriCure
ATRC
|
683 K | $ 61.13 | 3.66 % | $ 2.92 B | USA |
 |
Baxter International
BAX
|
290 M | $ 25.28 | -0.08 % | $ 13 B | USA |
 |
Microbot Medical
MBOT
|
-5 K | $ 0.95 | -2.44 % | $ 43.5 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
-8 K | - | - | $ 28.6 M | USA |
 |
Isoray
ISR
|
84 K | - | 0.03 % | $ 108 M | USA |
 |
Masimo Corporation
MASI
|
300 K | - | - | $ 9.59 B | USA |
 |
Predictive Oncology
POAI
|
3 | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
1.82 M | $ 38.61 | 3.51 % | $ 1.84 B | USA |
 |
Harvard Bioscience
HBIO
|
-2.66 M | $ 8.32 | 1.09 % | $ 369 M | USA |
 |
ICU Medical
ICUI
|
93.3 M | $ 165.91 | -0.46 % | $ 4.09 B | USA |
 |
InfuSystem Holdings
INFU
|
2 K | $ 13.8 | -1.0 % | $ 285 M | USA |
 |
iRhythm Technologies
IRTC
|
5.44 M | $ 121.86 | 0.49 % | $ 3.9 B | USA |
 |
LeMaitre Vascular
LMAT
|
5.18 M | $ 84.26 | -0.22 % | $ 1.91 B | USA |
 |
Nephros
NEPH
|
-78 K | $ 3.6 | 1.98 % | $ 38.2 M | USA |
 |
Envista Holdings Corporation
NVST
|
-2.3 M | $ 23.68 | 0.32 % | $ 3.98 B | USA |
 |
OraSure Technologies
OSUR
|
229 K | $ 4.17 | 0.97 % | $ 306 M | USA |
 |
Pro-Dex
PDEX
|
533 K | $ 61.53 | -1.11 % | $ 198 B | USA |
 |
Pulse Biosciences
PLSE
|
-52 K | $ 52.77 | -0.47 % | $ 3.56 B | USA |
 |
Repligen Corporation
RGEN
|
2.82 M | $ 180.01 | 1.74 % | $ 10.1 M | USA |
 |
ResMed
RMD
|
-9.15 M | $ 253.31 | 0.18 % | $ 36.9 B | USA |
 |
STAAR Surgical Company
STAA
|
2.25 M | $ 23.16 | 2.43 % | $ 1.15 B | USA |
 |
STERIS plc
STE
|
9.8 M | $ 229.89 | -0.97 % | $ 22.6 B | USA |
 |
Stereotaxis
STXS
|
2 K | $ 0.99 | -2.99 % | $ 90 M | USA |
 |
Teleflex Incorporated
TFX
|
85.1 M | $ 137.03 | 0.54 % | $ 6.11 B | USA |
 |
Utah Medical Products
UTMD
|
-120 K | $ 73.36 | -1.17 % | $ 238 M | USA |
 |
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M | USA |
 |
West Pharmaceutical Services
WST
|
-1 M | $ 395.17 | 0.77 % | $ 28.6 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
24 M | $ 9.22 | -2.28 % | $ 1.84 B | USA |
 |
AngioDynamics
ANGO
|
3.93 M | $ 12.17 | -1.62 % | $ 505 M | USA |
 |
Becton, Dickinson and Company
BDX
|
613 M | $ 195.87 | -1.37 % | $ 56.3 B | USA |
 |
The Cooper Companies
COO
|
-16.4 M | $ 61.11 | -0.16 % | $ 12.2 B | USA |
 |
electroCore
ECOR
|
14.9 K | $ 7.51 | 6.52 % | $ 63.7 K | USA |
 |
Glaukos Corporation
GKOS
|
479 K | $ 178.61 | -0.15 % | $ 10.2 B | USA |
 |
Haemonetics Corporation
HAE
|
-28.7 M | $ 119.33 | 0.69 % | $ 5.63 B | USA |